Gilead Sciences, Inc.(GILD)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
GILD | 182.89 B | - | 10.20% | -10.64% | -$2.63 | -20.68% | 2.23x | 2.18% | $157.29 | $109.66 |
950160.KQ | 1.45 T | - | - | - | - | - | - | - | $149000.00 | $11470.00 |
ABBV | 469.63 B | 75.72x | 10.20% | 9.80% | $3.51 | - | - | 2.63% | $269.39 | $189.40 |
950220.KQ | 66.65 B | - | 4559.30% | 0.00% | - | -61.03% | 0.20x | - | $4450.00 | $1115.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Gilead Sciences, Inc. (GILD) compared to its primary competitors (including 950160.KQ, ABBV, 950220.KQ) reveals distinct metrics. GILD trades at a valuation discount relative to its competitors, with a P/E ratio of -55.0x versus the peer average of 75.7x (representing a 173% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, GILD's revenue growth of 10.2% lags behind the peer average of 2284.8%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -10.6% is below the peer average of 4.9%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• GILD ranks #0 in P/E ratio, #2 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-05 | $143.21 | $145.16 | $142.79 | $144.63 | 6,137,600 | -0.08% |
| 2026-10-02 | $147.65 | $148.00 | $144.00 | $144.74 | 5,043,900 | -1.87% |
| 2026-10-01 | $149.44 | $149.44 | $147.19 | $147.50 | 4,438,500 | -1.04% |
| 2026-09-30 | $150.88 | $151.28 | $148.98 | $149.05 | 5,357,200 | -1.47% |
| 2026-09-29 | $150.18 | $152.63 | $148.79 | $151.28 | 5,322,400 | -0.61% |
| 2026-09-28 | $149.80 | $152.74 | $149.41 | $152.21 | 5,076,500 | +0.85% |
| 2026-09-25 | $150.05 | $151.00 | $148.02 | $150.93 | 5,284,300 | +0.83% |
| 2026-09-24 | $151.10 | $152.98 | $149.59 | $149.69 | 5,074,700 | -1.11% |
| 2026-09-23 | $153.60 | $154.20 | $150.06 | $151.37 | 6,191,700 | -0.85% |
| 2026-09-22 | $150.65 | $153.28 | $148.65 | $152.67 | 5,080,000 | +1.40% |
| 2026-09-21 | $150.11 | $152.10 | $148.22 | $150.56 | 5,569,200 | +0.30% |
| 2026-09-18 | $150.56 | $153.23 | $149.57 | $150.11 | 16,412,100 | -0.52% |
| 2026-09-17 | $148.78 | $151.04 | $146.89 | $150.89 | 7,842,200 | +2.17% |
| 2026-09-16 | $146.58 | $149.30 | $146.12 | $147.68 | 5,187,900 | +0.94% |
| 2026-09-15 | $144.00 | $146.35 | $142.94 | $146.30 | 4,532,600 | +0.49% |
Explore More Analysis for GILD
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.